A recent study investigating the influence of obesity on IDD has identified CXCL16 as a potential diagnostic biomarker for both obesity and IDD, highlighting its role in regulating fatty acid metabolism and facilitating IDD progression (12). This evidence concerns the gene CXCL16 and Obesity.